A New Zealand linkage study examining the associations between A1C concentration and mortality

Diabetes Care

Volumn 31, Issue 6, 2008, Pages 1144-1149

  Brewer, Naomi ^a   Wright, Craig S ^b   Travier, Noémie ^a   Cunningham, Chris W ^c   Hornell, John ^d   Pearce, Neil ^a   Jeffreys, Mona ^a  

^a MASSEY UNIVERSITY   (New Zealand)

^b MINISTRY OF HEALTH   (New Zealand)

^c MASSEY UNIVERSITY   (New Zealand)

^d Hepatitis Foundation   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADOLESCENT; ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; DIABETES MELLITUS; ENDOCRINE DISEASE; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; IMMUNOPATHOLOGY; INFANT; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MORTALITY; NEW ZEALAND; NEWBORN; NUTRITIONAL DISORDER; POPULATION RESEARCH; PRESCHOOL CHILD; SCHOOL CHILD; SCREENING; SEX DIFFERENCE; SMOKING; ETHNIC GROUP; HEALTH SURVEY; METABOLISM; REPRODUCIBILITY; RISK FACTOR;

CAUSE OF DEATH; DIABETES MELLITUS; ETHNIC GROUPS; FEMALE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; NEW ZEALAND; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SMOKING;

EID: 48649103350     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2374     Document Type: Article

References (23)

1. Sacks DB, Brans DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 25:750-786, 2002
2. Sacks DB, Bruns DE, Goldstein DE, Ma-claren NK, McDonald JM, Parrott M: Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 48:436-472, 2002
3. Steinbrook R: Facing the diabetes epidemic: mandatory reporting of glycosylated hemoglobin values in New York City. N Engl J Med 354:545-548, 2006
4. Bennett CM, Guo M, Dharmage SC: HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 24:333-343, 2007
5. Miyazaki M, Kubo M, Kiyohara Y, Okubo K, Nakamura H, Fujisawa K, Hata Y, Tokunaga S, Iida M, Nose Y, Ishibashi T, the Hisayama Study: Comparison of diagnostic methods for diabetes mellitus based on prevalence of retinopathy in a Japanese population: the Hisayama Study. Diabeto-logia 47:1411-1415, 2004
6. Norberg M, Eriksson JW, Lindahl B, Andersson C, Rolandsson O, Stenlund H, Weinehall L: A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J Intern Med 260:263-271, 2006
7. Pfab T, Slowinski T, Godes M, Halle H, Priem F, Hocher B: Low birth weight, a risk factor for cardiovascular diseases in later life, is already associated with elevated fetal glycosylated hemoglobin at birth. Circulation 114:1687-1692, 2006
8. de de Vegt F, Dekker JM, Ruhe HG, Ste-houwer CD, Nijpels G, Bouter LM, Heine RJ: Hyperglycaemia is associated with all- cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Dia-betologia 42:926-931, 1999
9. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). Br Med J 322:15B-18B, 2001
10. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A(1c) with cardiovascular disease and mortality in adults: the European Prospective Investigation Into Can-cer in Norfolk. Ann Intern Med 141:413-420, 2004
11. Nakanishi S, Yamada M, Hattori N, Suzuki G: Relationship between HbA(1)c and mortality in a Japanese population. Diabetologia 48:230-234, 2005
12. Park S, BarrettConnor E, Wingard DL, Shan J, Edelstein S: GHb is a better predictor at cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes: the Rancho Bernardo study. Diabetes Care 19:450-456, 1996
13. Shankar A, Klein R, Klein BEK, Moss SE: Association between glycosylated hemoglobin level and cardiovascular and all- cause mortality in type 1 diabetes. Am J Epidemiol 166:393-402, 2007
14. Menon V, Greene T, Pereira AA, Wang X, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ: Glycosylated hemoglobin and mortality in patients with nondiabetic chronic kidney disease. JAm Soc Nephrol 16:3411-3417, 2005
15. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR, Golden SH: Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431, 2004
16. Travier N, Jeffreys M, Brewer N, Wright CS, Cunningham CW, Hornell J, Pearce N: Association between glycosylated hemoglobin and cancer risk: a New Zealand linkage study. Ann Oncol 18:1414-1419, 2007
17. New Zealand Department of Statistics: Ethnicity in New Zealand: Recommendations for a Standard Classification. Wellington, New Zealand, Department of Statistics, 1990
18. Armitage P, Berry G, Matthews JNS. Statistical Methods in Medical Research. 4thed. Oxford, Blackwell Science, 2002
19. Chen F, Florkowski C, Dever M, Beaven D: Diabetes mellitus: an under-recognised health problem in New Zealand (Letter). N Z Med J 117:U828, 2004
20. Coppell K, McBride K, Williams S: Under-reporting of diabetes on death certificates among a population with diabetes in Otago Province, New Zealand. N Z Med J 117:U1217, 2004
21. Pradhan AD, Rifai N, Buring JE, Ridker PM: Hemoglobin a1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med 120:720 -727, 2007
22. Blake GJ, Pradhan AD, Manson JE, Williams GR, Buring J, Ridker PM, Glynn RJ: Hemoglobin A(1c) level and future cardiovascular events among women. Arch Intern Med 164:757-761, 2004
23. Diop ME, Bastard JP, Meunier N, Thevenet S, Maachi M, Capeau J, Pialoux G, Vigouroux C: Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses 22:1242-1247, 2006